Stocks News

LAST PRICE
87.2200
TODAY'S CHANGE (%)
Trending Down-1.6200 (-1.8235%)

Bid / Lots
86.2700/ 2
Ask / Lots
88.6000/ 1
Open / Previous Close
88.4900 / 88.8400
Day Range
Low 86.8800
High 88.8800
52 Week Range
Low 55.0200
High 98.4000
Volume
363,121
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Oct 29, 2024
- Axsome Therapeutics Presents Data from Multiple Programs Spanning Its Innovative Neuroscience Portfolio at Psych Congress 2024, from 7:00AM ET on Tuesday Oct 29, 2024 by Dow Jones
  7:00AM ET on Tuesday Oct 29, 2024 by Dow Jones
  Companies Mentioned: AXSM
  
  Axsome Therapeutics Presents Data from Multiple Programs Spanning Its Innovative Neuroscience Portfolio at Psych Congress 2024
  
  NEW YORK, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced seven presentations from across its broad portfolio of innovative neuroscience products and product candidates at Psych Congress 2024, being held Oct. 29 - Nov. 2, 2024, in Boston, Massachusetts.
Oct 15, 2024
- Axsome Therapeutics to Report Third Quarter 2024 Financial Results on November 12, from 7:00AM ET on Tuesday Oct 15, 2024 by Dow Jones
  7:00AM ET on Tuesday Oct 15, 2024 by Dow Jones
  Companies Mentioned: AXSM
  
  Axsome Therapeutics to Report Third Quarter 2024 Financial Results on November 12
  
  NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, will report its financial results for the third quarter of 2024 on Tuesday, November 12, 2024, before the opening of the U.S. financial markets. Axsome management will then host a conference call at 8:00 a.m. Eastern Time to discuss these results and provide a business update.

Today
- Did ADMA Biologics Commit Securities Fraud Resulting in 20% Stock Drop? Contact BFA Law about its Ongoing Securities Fraud Investigation (Nasdaq:ADMA), from 6 hours ago by Dow Jones
  6 hours ago by Dow Jones
  Companies Mentioned: ADMA
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA, from 6 hours ago by Dow Jones
  6 hours ago by Dow Jones
  Companies Mentioned: ADMA
- Sector Update: Health Care Stocks Mixed Premarket Monday, from 12 hours ago by MT Newswires
  12 hours ago by MT Newswires
  Companies Mentioned: IBB, TGTX, XLV, ZTS, BNTX
- TG Therapeutics Q3 Earnings, Revenue Fall, from 14 hours ago by MT Newswires
  14 hours ago by MT Newswires
  Companies Mentioned: TGTX
- -- Earnings Flash (TGTX) TG THERAPEUTICS Posts Q3 Revenue $83.9M, from 14 hours ago by MT Newswires
  14 hours ago by MT Newswires
  Companies Mentioned: TGTX
- TG Therapeutics Reports Third Quarter 2024 Financial Results and Raises BRIUMVI(R) (ublituximab-xiiy) Full Year Revenue Guidance, from 14 hours ago by Dow Jones
  14 hours ago by Dow Jones
  Companies Mentioned: TGTX
- *DJ TG Therapeutics 3Q EPS 2c >TGTX, from 14 hours ago by Dow Jones
  14 hours ago by Dow Jones
  Companies Mentioned: TGTX
- ADMA INQUIRY ALERT: A Securities Fraud Investigation has been Initiated against ADMA Biologics into the Auditor Resignation; Investors with Losses are Urged to Contact the Firm (Nasdaq:ADMA), from 15 hours ago by Dow Jones
  15 hours ago by Dow Jones
  Companies Mentioned: ADMA
Yesterday
- BFA Law Announces ADMA BIOLOGICS Is Being Investigated for Securities Fraud After Auditor Resigned and Urges Investors Who Lost Money to Contact the Firm, from 8:34AM ET on Sunday Nov 03, 2024 by Newsfile
  8:34AM ET on Sunday Nov 03, 2024 by Newsfile
  Companies Mentioned: ADMA
- BFA Law Announces ADMA BIOLOGICS Is Being Investigated for Securities Fraud After Auditor Resigned and Urges Investors Who Lost Money to Contact the Firm, from 8:34AM ET on Sunday Nov 03, 2024 by Dow Jones
  8:34AM ET on Sunday Nov 03, 2024 by Dow Jones
  Companies Mentioned: ADMA

Axsome Therapeutics Inc
NASDAQ:AXSMUnited States

Search Criteria

Oct 29, 2024

Axsome Therapeutics Presents Data from Multiple Programs Spanning Its Innovative Neuroscience Portfolio at Psych Congress 2024, from 7:00AM ET on Tuesday Oct 29, 2024 by Dow Jones

Oct 15, 2024

Axsome Therapeutics to Report Third Quarter 2024 Financial Results on November 12, from 7:00AM ET on Tuesday Oct 15, 2024 by Dow Jones

Peers Headlines

Today

Did ADMA Biologics Commit Securities Fraud Resulting in 20% Stock Drop? Contact BFA Law about its Ongoing Securities Fraud Investigation (Nasdaq:ADMA), from 6 hours ago by Dow Jones

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA, from 6 hours ago by Dow Jones

Sector Update: Health Care Stocks Mixed Premarket Monday, from 12 hours ago by MT Newswires

TG Therapeutics Q3 Earnings, Revenue Fall, from 14 hours ago by MT Newswires

-- Earnings Flash (TGTX) TG THERAPEUTICS Posts Q3 Revenue $83.9M, from 14 hours ago by MT Newswires

TG Therapeutics Reports Third Quarter 2024 Financial Results and Raises BRIUMVI(R) (ublituximab-xiiy) Full Year Revenue Guidance, from 14 hours ago by Dow Jones

*DJ TG Therapeutics 3Q EPS 2c >TGTX, from 14 hours ago by Dow Jones

ADMA INQUIRY ALERT: A Securities Fraud Investigation has been Initiated against ADMA Biologics into the Auditor Resignation; Investors with Losses are Urged to Contact the Firm (Nasdaq:ADMA), from 15 hours ago by Dow Jones

Yesterday

BFA Law Announces ADMA BIOLOGICS Is Being Investigated for Securities Fraud After Auditor Resigned and Urges Investors Who Lost Money to Contact the Firm, from 8:34AM ET on Sunday Nov 03, 2024 by Newsfile

BFA Law Announces ADMA BIOLOGICS Is Being Investigated for Securities Fraud After Auditor Resigned and Urges Investors Who Lost Money to Contact the Firm, from 8:34AM ET on Sunday Nov 03, 2024 by Dow Jones